Analysts project a potential breakout if support at $102 holds, driven by strong consumer spending data. Economists were expecting to see the US added 50,000 jobs in September, according to Bloomberg consensus estimates as of Sept. 26. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. With "stock price t" fluctuating near $98, sector rotation from growth to value stocks is impacting momentum. Fund managers report cash inflows into defensive plays, signaling cautious optimism ahead of the Fed's rate decision.
